Pandemic Takes Toll on Treatment for Substance Use Disorders, Mental Health: WHO

    A new survey by the World Health Organization (WHO) finds the COVID-19 pandemic has taken a toll on treatment services for substance use disorders and mental health worldwide, Reuters reports.

    Countries reported widespread disruption of many critical services, according to the survey. The survey found 57% of countries saw disruptions to counseling and psychotherapy; 65% to critical harm reduction services; and 45% to opioid agonist maintenance treatment for opioid dependence.

    Thirty percent of countries reported disruptions to access for medications for mental, neurological and substance use disorders. In addition, 35% of countries reported disruptions to emergency interventions, including those for people experiencing prolonged seizures; severe substance use withdrawal syndromes; and delirium, often a sign of a serious underlying medical condition.

    “We estimate, and preliminary information is telling us, that there may be an increase in people with mental, neurological and substance abuse-related conditions that will need attention,” said Devora Kestel, Director of WHO’s Department of Mental Health and Substance Use.

    By Partnership Staff
    October 2020


    October 2020


    Sign up to join our community working to end addiction.

    Please leave this field empty

    By entering your email address above you are opting in to receive email communications from Partnership to End Addiction and agreeing to our Terms of Use and Privacy Policy.

    No, thanks. Take me to the website.